$Xtant Medical(XTNT.US)$Revenue of $27.9 million, up 55%, compared to the prior year quarter Gross margin of 62.1%, up 340 basis points, compared to the prior year quarter Net loss of $4.4 million compared to $2.1 million in the year ago quarter Positive Adjusted EBITDA; Adjusted EBITDA of $0.1 million compared to an Adjusted EBITDA loss of $0.3 million in the prior year quarter
Xtant Medical股票討論區
Gross margin of 62.1%, up 340 basis points, compared to the prior year quarter
Net loss of $4.4 million compared to $2.1 million in the year ago quarter
Positive Adjusted EBITDA; Adjusted EBITDA of $0.1 million compared to an Adjusted EBITDA loss of $0.3 million in the prior year quarter
2023 年第四季的毛利率為 61.0%,相比...
將 2023 年年度收入指引提高至 8.800 萬美元至 91 億美元
暫無評論